- Home
- RNG vs INDV Comparison
RNG vs INDV Comparison
Compare RNG & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RNG | INDV |
|---|---|---|
| Founded | 1999 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.2B | 3.7B |
| IPO Year | 2013 | 2014 |
Fundamental Metrics
Financial Performance| Metric | RNG | INDV |
|---|---|---|
| Price | $37.04 | $32.96 |
| Analyst Decision | Hold | |
| Analyst Count | 14 | 0 |
| Target Price | ★ $33.58 | N/A |
| AVG Volume (30 Days) | 1.4M | ★ 2.3M |
| Earning Date | 05-07-2026 | 06-08-2026 |
| Dividend Yield | ★ 0.81% | N/A |
| EPS Growth | 176.19 | ★ 8100.00 |
| EPS | 0.48 | ★ 1.64 |
| Revenue | ★ $2,515,142,000.00 | $1,239,000,000.00 |
| Revenue This Year | $5.56 | N/A |
| Revenue Next Year | $4.56 | N/A |
| P/E Ratio | $76.99 | ★ $19.28 |
| Revenue Growth | ★ 4.78 | 4.29 |
| 52 Week Low | $21.91 | $8.69 |
| 52 Week High | $42.42 | $38.00 |
Technical Indicators
Market Signals| Indicator | RNG | INDV |
|---|---|---|
| Relative Strength Index (RSI) | 52.37 | 57.58 |
| Support Level | $25.58 | $31.70 |
| Resistance Level | $39.74 | $35.75 |
| Average True Range (ATR) | 2.16 | 1.17 |
| MACD | -0.28 | 0.37 |
| Stochastic Oscillator | 66.55 | 98.05 |
Price Performance
Historical ComparisonAbout RNG RingCentral Inc.
RingCentral is a unified communications as a service, or UCaaS, provider. Its software helps users communicate and collaborate via voice, video, and messaging across all device types and all from one platform. RingCentral helps customers modernize and move from legacy on-premises systems to modern, cloud-based systems. Beyond its core RingCentral MVP solution, RingCentral also offers a cloud-based contact center solution, a stand-alone video meetings solution, and webinars.
About INDV Indivior PLC
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).